The global Generic drugs market is valued at around USD 290.83 billion in 2018 and is expected to attain USD 412.50 billion by 2023 with a CAGR of 7.24%. A Generic drug is a pharmaceutical drug, which has the equal chemical substance as the first developed drug. Generic drugs are allowed for profits after patent(s) on unique drug expired. Because the active chemical substance is the same, the medical profile of generics is thought about as being identical in overall performance.
Increasing number of patent expiration of branded capsules is propelling the growth of the market
Factors affecting market growth:
Increasing the prevalence of persistent sicknesses (+) Low cost of the drugs (+) Outsourcing of the manufacturing process (+) Increasing number of patent expiration of branded capsules (+) Increasing geriatric population (+) High competition and the shortage of drugs (-) Threat of using counterfeit capsules (-) Get your customized report: https://www.marketdataforecast.com/market-reports/global-generic-drugs-market-2183/customize-report
Super Generics segment holds the largest share of the market
Market Segmentation
The Global Generic drugs market is segmented on the basis of
Type
Introduction Biosimilars Simple generics Super generics Therapeutic drugs
Introduction Cardiovascular Products Anti-infective Drugs Anti Arthritis Drugs Central Nervous System Drugs Anti Cancer Drugs Respiratory System Drugs Others Super generics are bought at a better rate than their pure usual counterpart. Super generics account for 18% of overall spending on generic drugs.
The main industries of the market include Ranbaxy Laboratories, Ltd, Actavis, Mylan, Inc., Industries, Ltd., and Dr. Reddy’s Laboratories, Par Pharmaceutical, Inc., Sandoz International GmbH, Hospira, Inc., Apotex, Inc., Watson Pharmaceuticals, Ltd., Teva Pharmaceutical and others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: